EUVIMEDEUVIMED entdecken
Open Access

Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis

Samar A Antar, Eric Mensah, Jacob Dahlka, Mark C Renton, Ahmed A Raslan, Michael Aziz, Aymen Halouani, Seun Imani, Aanandi Parashar, Scott R Johnstone, Robert Benezra, Diego Fraidenraich und 2 weitere

Theranostics · 2026

DOI: 10.7150/thno.127118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Samar A Antar und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fralin Biomedical Research Institute at Virginia Tech Carilion, Virginia, USA. Hauptthemen laut MEDLINE: Inhibitor of Differentiation Protein 1, Inhibitor of Differentiation Proteins, Fibroblasts, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inhibitor of Differentiation Protein 1Inhibitor of Differentiation ProteinsFibroblastsIdiopathic Pulmonary FibrosisMAP Kinase Signaling SystemPulmonary FibrosisAnimalsHumansMiceLungCell ProliferationCell CycleCell DifferentiationCell MovementTransforming Growth Factor betaMice, Inbred C57BLMaleBleomycinCells, CulturedDisease Models, AnimalNeoplasm Proteins

Stichwörter der Autor:innen

ID proteinsbleomycinidiopathic pulmonary fibrosislung fibroblast

Substanzen

Inhibitor of Differentiation Protein 1Inhibitor of Differentiation ProteinsID3 protein, humanID1 protein, humanIdb1 protein, mouseIdb3 protein, mouseTransforming Growth Factor betaBleomycinNeoplasm Proteins

Autor:innen und Institutionen

  • Fralin Biomedical Research Institute at Virginia Tech Carilion, Virginia, USA.
  • Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
  • Icahn School of Medicine at Mount Sinai, New York, USA.
  • Arthritis and Autoimmune Diseases Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Pulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Department of Zoology, Faculty of Science, Assiut University, Assiut, Egypt.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Antar, S. A., Mensah, E., Dahlka, J., Renton, M. C., Raslan, A. A., Aziz, M., Halouani, A., Imani, S., Parashar, A., Johnstone, S. R., Benezra, R., Fraidenraich, D., Ligresti, G., & Sassi, Y. (2026). Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis. Theranostics. https://doi.org/10.7150/thno.127118

Vancouver

Antar SA, Mensah E, Dahlka J, Renton MC, Raslan AA, Aziz M, et al. Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis. Theranostics. 2026. doi:10.7150/thno.127118

BibTeX
@article{Antar2026,
  author = {Antar, Samar A and Mensah, Eric and Dahlka, Jacob and Renton, Mark C and Raslan, Ahmed A and Aziz, Michael and Halouani, Aymen and Imani, Seun and Parashar, Aanandi and Johnstone, Scott R and Benezra, Robert and Fraidenraich, Diego and Ligresti, Giovanni and Sassi, Yassine},
  title = {Simultaneous inhibition of ID1 and ID3 mitigates fibroblast activation via cell cycle and MEK/ERK pathways in pulmonary fibrosis},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.127118}
}
Kostenlos starten →